Press Releases McKesson Corporation

Equities

MCK

US58155Q1031

Real-time Estimate Cboe BZX Other stock markets 12:16:11 01/05/2024 am IST			5-day change	1st Jan Change
537.6 ^USD	+0.29%		+1.30%	+16.40%

02:07pm	Citigroup Adjusts Price Target on McKesson to $620 From $575	MT
24/04	McKesson Keeps Quarterly Dividend at $0.62 Per Share; Payable July 1 to Shareholders of Record on June 3	MT

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

McKesson : OJEMDA FDA Approved for Pediatric Low Grade Glioma	26/04	PU
McKesson : Ontada Names Jade Cusick Chief Commercial Officer	25/04	PU
McKesson Corporation Declares Quarterly Dividend	24/04	BU
McKesson Launches Project Oasis to Address Pharmacy Deserts in Underserved Communities	03/04	AQ
Significant Implications For FCA Defendants: Second Circuit Clarifies "Willfulness" In McKesson Decision	03/04	AQ
"Willfulness" As "Knowledge Of Illegality": Second Circuit Adopts Prevailing Federal AKS Scienter Interpretation While Reviving State FCA Claims Over Potentially Different State AKS Scienter Standards	02/04	AQ
McKesson Corporation Announces Fourth Quarter Fiscal 2024 Earnings Release Date	28/03	BU
McKesson Invites Community Pharmacists to Push the Industry Forward, Together	15/03	AQ
McKesson : Barclays Global Healthcare Conference Transcript	14/03	PU
Thinking about trading options or stock in NVIDIA, Arm Holdings, Cisco Systems, McKesson, or Roku?	20/02	PR
McKesson: Fiscal Q3 Earnings Snapshot	08/02	AQ
McKesson Corporation Reports Fiscal 2024 Third Quarter Results and Raises Full Year Guidance	08/02	BU
McKesson Corporation Declares Quarterly Dividend	01/02	BU
McKesson to Present at the 42nd Annual J.P. Morgan Healthcare Conference	09/01	BU
Treble Damages Require Willful, Knowing Conduct, Ninth Circuit Says	03/01	AQ
McKesson Corporation Announces Third Quarter Fiscal 2024 Earnings Release Date and Participation in January Conference	28/12	BU
McKesson : FABHALTA (iptacopan), FDA Approved for the Treatment of Adults with Paroxysmal Nocturnal Hemoglobinuria, Available at Biologics by McKesson	20/12	PU
McKesson : OGSIVEO (nirogacestat) FDA Approved for Desmoid Tumors, Available at Biologics by McKesson	05/12	PU
TRUQAP, FDA Approved for the Treatment of Breast Cancer, Available at Biologics by McKesson	04/12	AQ
McKesson : TRUQAP (capivasertib), FDA Approved for the Treatment of Breast Cancer, Available at Biologics by McKesson	02/12	PU

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases McKesson Corporation

Equities

MCK

US58155Q1031

Press Releases

Filters